Redwood Investments’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.11M Sell
37,067
-54
-0.1% -$1.65K 0.41% 76
2024
Q4
$1.06M Sell
37,121
-39
-0.1% -$1.29K 0.28% 84
2024
Q3
$1.44M Buy
37,160
+9,046
+32% +$323K 0.43% 77
2024
Q2
$899K Buy
28,114
+22,220
+377% +$770K 0.31% 94
2024
Q1
$229K Buy
+5,894
New +$206K 0.07% 116

Other funds holding COLL

Redwood Investments's COLL Position: Q1 2025 in Review

Redwood Investments reduced its Collegium Pharmaceutical (COLL) stake by 0.15% in Q1 2025, selling an estimated $1.65K and leaving 37,067 shares worth $1.11M. The position accounts for 0.41% of the portfolio, ranked #76.

Redwood Investments first reported a position in COLL in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.44M in Q3 2024. 242 funds tracked by Wall St. Rank hold COLL as of Q1 2025.

  • Redwood Investments held 37,067 shares of Collegium Pharmaceutical worth $1.11M as of Q1 2025.
  • Redwood Investments sold 54 Collegium Pharmaceutical shares in Q1 2025, an estimated $1.65K.
  • Collegium Pharmaceutical made up 0.41% of Redwood Investments's portfolio in Q1 2025, its #76 holding.
  • Redwood Investments first reported a position in Collegium Pharmaceutical in Q1 2024 and has held it in 5 quarters since.
  • Redwood Investments's Collegium Pharmaceutical position peaked at $1.44M in Q3 2024.
  • 242 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2025.

Based on Redwood Investments's 13F filing for Q1 2025, filed 16 May 2025.